Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EH
- Chemical substanceL01EH02Neratinib
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 2 medicines
Brazil
Anvisa · 1 medicine
Canada
Health Canada · 1 medicine
Spain
AEMPS · 1 medicine



